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Background. Antibiotic use prior to seeking care at a hospital may reduce the sensitivity of blood culture for enteric fever, with
implications for both clinical care and surveillance. The Surveillance for Enteric Fever in Asia Project (SEAP) is a prospective study
of enteric fever incidence in Nepal, Bangladesh, and Pakistan. Nested within SEAP, we evaluated the accuracy of self-reported antibiotic use and investigated the association between antibiotic use and blood culture positivity.
Methods. Between November 2016 and April 2019, we collected urine samples among a subset of SEAP participants to test for
antibiotic use prior to the hospital visit using an antibacterial activity assay. All participants were asked about recent antibiotic use
and had a blood culture performed. We used mixed-effect logit models to evaluate the effect of antimicrobial use on blood culture
positivity, adjusted for markers of disease severity.
Results. We enrolled 2939 patients with suspected enteric fever. Antibiotics were detected in 39% (1145/2939) of urine samples.
The correlation between measured and reported antibiotic use was modest (κ = 0.72). After adjusting for disease severity, patients
with antibiotics in their urine were slightly more likely to be blood culture positive for enteric fever; however, the effect was not statistically significant (prevalence ratio, 1.22 [95% confidence interval, .99–1.50]).
Conclusions. The reliability of self-reported prior antibiotic use was modest among individuals presenting with fever to tertiary
hospitals. While antibiotics are likely to reduce the sensitivity of blood culture, our findings indicate that there is still considerable
value in performing blood culture for individuals reporting antibiotic use.
Keywords. enteric fever; typhoid; antimicrobial resistance; blood culture.
Enteric fever, caused by Salmonella enterica subspecies enterica
serotypes Typhi and Paratyphi A, is a major cause of morbidity
in South Asia [1]. Antibiotic treatment is one of the mainstays
of enteric fever management and is responsible for a marked
reduction in mortality from a disease that had a case fatality
rate of 10%–25% in the pre–antibiotic era [2]. Unfortunately,
accurate diagnosis of enteric fever remains a major challenge.
Enteric fever is difficult to distinguish clinically from other
causes of acute febrile illness [3–5], and there are no rapid diagnostic tests available to inform appropriate therapy with
a
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sufficient accuracy [6, 7]. Blood cultures have low sensitivity of
50%–60% and take 48–72 hours to provide results, which limits
their utility in clinical decision-making [8].
Antibiotic use prior to seeking care at a hospital may reduce the sensitivity of blood culture for enteric fever [8, 9],
with implications for both clinical care and surveillance. In
resource-constrained environments, it is sometimes questioned whether there is sufficient value in performing blood
culture among individuals who report recent antibiotic use,
because of the perceived impact that antibiotic use has on the
yield of blood cultures. However, ascertaining antimicrobial
use accurately is difficult. In contexts where antimicrobials are
easily available, few pharmaceutical records exist, and many
people struggle to distinguish antibiotics from other medications such as antipyretics or antidiarrheal. Relying on self- or
caregiver-reported antibiotic use can be misleading [10–13].
Urine antibacterial assays quantify antibiotic presence in the
urine and are an appealing alternative to reported antibiotic
use [14], particularly in settings where antibiotics are widely
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Antibiotic Use Prior to Hospital Presentation Among
Individuals With Suspected Enteric Fever in Nepal,
Bangladesh, and Pakistan

Measurements and Definitions

Statistical Analysis

The eligibility criteria of 3 or more consecutive days of fever
in the previous 7 days was assessed by self-report or caregiver
report. We interviewed all study participants, using a standardized questionnaire to ascertain demographic and clinical history. A sample of peripheral venous blood was collected from

The primary outcome was the presence of antibiotics in the
urine as measured by the biological assay described above. We
reported the proportion of participants with antibiotics detected in their urine samples, along with 95% confidence intervals (CIs), stratified by country and age. We used principal

MATERIALS AND METHODS
Overall Design

This study was nested within the SEAP study, a longitudinal
surveillance study for typhoid and paratyphoid fevers in
Bangladesh, Nepal, and Pakistan. SEAP study methods are presented elsewhere [16, 17]. Individuals presenting to outpatient
departments with 3 or more consecutive days of fever in the
prior 7 days were eligible to enroll in SEAP. We collected urine
samples from a subset of this population to test for the presence
of antimicrobial activity and inquired about their antibiotic use.
Study Population
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SEAP patients presenting to the outpatient department at any
of the 6 study hospitals with 3 or more consecutive days of fever
were eligible to participate. Participants were enrolled consecutively from September 2016 through April 2019 until the
target sample size was reached. All study hospitals were tertiary
facilities: 2 in Dhaka, Bangladesh; 1 in Kathmandu, Nepal; 1
in Kavrepalanchok, Nepal; and 2 in Karachi, Pakistan. While
participants of any age were eligible to participate, the hospital
study sites in Bangladesh serve primarily pediatric populations.

each participant, inoculated into a BACTEC Aerobic bottle or
PED Plus bottle, and incubated in a BACTEC system for 5 days.
One blood culture was performed per patient. Samples that indicated positivity in the BACTEC system were subcultured onto
MacConkey agar plates and nonselective media (sheep blood
agar). We identified the species with biochemical testing and
confirmed serologically, using O and H antisera (BD laboratories), when available.
We also requested a sample of at least 3 mL of urine in a sterile
collection cup from the participants before any antibiotics were prescribed or administered at the study facility. Urine was collected the
same day blood was drawn for culture. These samples were either
processed immediately or stored at 2°C–8°C and processed the following day or stored at −80°C and processed within a month. In an
internal validation study of 10 samples, there was no difference in
susceptibility between fresh samples and samples stored at −20°C
and −80°C for up to 3 months’ storage time.
To test for the presence of antibiotics, we prepared a bacterial lawn of Kocuria rhizophila (previously Micrococcus luteus)
(ATCC:9341) on Mueller-Hinton agar (Oxoid: CM033) with 5%
sheep’s blood. Kocuria rhizophila has been previously used to
detect low concentrations of antibiotics in biological fluids because of its high susceptibility to antibiotics [18, 19]. We placed
a type of sterile blank disk (Oxoid: CT998) used in Kirby-Bauer
disk diffusion testing on the lawn of bacteria and added 8–10 µL
of the urine sample to the disk. After incubating the plate for 24
hours at 37°C, we measured the zone of inhibition around the
disk. Any zone of inhibition around the disk was interpreted as
detection of antibiotics in the urine. We did quality control of
the media during the preparation of each batch, by testing the
positive and negative control disks on the bacterial lawn.
We inquired about care-seeking and antibiotic use in the
7 days prior to presenting for care at the study facility by asking
the following questions to all participants: “For this febrile illness, before arriving for this visit, did you/the participant seek
any type of medical advice or treatment for your/their symptoms, such as a health clinic, other hospital, pharmacy, or private healthcare provider?” and “Before arriving for this visit, did
you/the participant take any of the following medications, such
as antibiotics, antipyretics, analgesics, and antidiarrheals?”
We did not collect additional information on the specific antibiotics consumed. We also collected information about household assets, education and self-reported clinical symptoms. If
the participants were <15 years old, we asked these questions to
their caregiver or guardian.

available and antibiotic knowledge and awareness are known
to be low.
Easy access and indiscriminate use of antibiotics prior to
formal care may be an important contributor to the emerging
threat of antimicrobial resistance. Rising rates of antimicrobial resistance may undermine treatment effectiveness for enteric fever as well as other infectious diseases [15]. Critically,
the empiric use of antibiotics in patients with nonspecific febrile illnesses, suspected of having enteric fever, may have implications for antibacterial resistance beyond that of typhoidal
Salmonella. Therefore, measuring patterns of antibiotic use for
febrile illness in enteric-fever endemic settings may enhance
our understanding of the drivers of antimicrobial resistance.
To investigate patterns of antibiotic use among patients
with acute febrile illness, we conducted a substudy among patients presenting to outpatient departments who were enrolled
in the Surveillance for Enteric Fever in Asia Project (SEAP)
study sites in Bangladesh, Nepal, and Pakistan. Our objectives
were to characterize prehospital antibiotic use among patients
with suspected enteric fever in South Asia according to demographic and clinical characteristics, evaluate the accuracy of
self-reported antibiotic use, and investigate the relationship between antibiotic use and culture positivity.

Table 1. Characteristics of Enrolled Patients With Enteric Fever by
Country, Surveillance for Enteric Fever in Asia Project—Bangladesh,
Nepal, and Pakistan, 2016–2019

Characteristic
Female sex

Bangladesh
Nepal
(n = 999)
(n = 1001)
423 (42.3)

All participants gave informed consent; in the case of minors,
verbal assent and informed consent were provided by a parent
or guardian. The study was approved by the Nepal Health
Research Council, Bangladesh Institute of Child Health Ethical
Review Committee, Pakistan Ethical Review Committee,
the US Centers for Disease Control and Prevention, and the
Institutional Review Board at Stanford University.

Total
(N = 2939)

410 (43.7)

1246 (42.4)

Age, y
<2

77 (7.7)

19 (1.9)

32 (3.4)

128 (4.4)

2–4

370 (37.0)

105 (10.5)

102 (10.9)

577 (19.6)

5–15

552 (55.3)

232 (23.2)

310 (33.0)

1094 (37.2)

16–25

0 (0.0)

248 (24.8)

138 (14.7)

386 (13.1)

>25

0 (0.0)

397 (39.7)

357 (38.0)

754 (25.7)

Temperature at hospital presentation, °C
Median
IQR

37.3

37.2

37.5

37.2

36.6–38

36.6–38.1

36.7–38.3

36.7–38.2

Days of fever before hospital presentation
Median
IQR

4.0

4.0

5.0

4.0

3.0–6.0

3.0–5.0

3.0–6.0

3.0–6.0

Days unable to complete normal activity
Median
IQR
Reported diarrhea
Diagnosed with enteric
fever

2.0

3.0

3.0

3.0

0.0–4.0

2.0–5.0

2.0–5.0

1.0–5.0

62 (6.2)

109 (10.9)

163 (17.4)

334 (11.4)

816 (81.7)

198 (19.8)

466 (49.7)

1480 (50.4)

36 (3.6)

136 (14.5)

373 (12.7)

Blood culture positive for 201 (20.1)
S. Typhi or S. Paratyphi

Ethics Statement

413 (41.3)

Pakistan
(n = 939)

Antibiotics detected in
urine

377 (37.7)

264 (26.4)

504 (53.8)

1145 (39.0)

Antibiotic use reported

412 (42.4)

417 (42.4)

430 (46.2)

1259 (43.7)

Prior care-seeking
Hospital

97 (21.5)

171 (22.1)

340 (47.2)

608 (31.3)

247 (56.7)

461 (59.6)

17 (2.4)

725 (37.7)

3 (0.7)

144 (18.6)

239 (33.9)

386 (20.0)

Physician

78 (17.3)

5 (0.6)

210 (29.5)

293 (15.1)

Traditional healer

11 (2.4)

1 (0.1)

3 (0.4)

15 (0.8)

1 (lowest)

79 (18.0)

22 (5.2)

173 (34.5)

274 (20.1)

2

68 (15.5)

74 (17.4)

131 (26.1)

273 (20.0)

3

67 (15.3)

91 (21.4)

115 (22.9)

273 (20.0)

4

87 (19.8)

104 (24.5)

82 (16.3)

273 (20.0)

138 (31.4)

134 (31.5)

1 (0.2)

273 (20.0)

Pharmacy
Clinic

Wealth index quintile

RESULTS

We recruited 2939 individuals presenting to the outpatient department at SEAP study hospitals with a fever of 3 or more days
in the past week. This included 999 participants in Bangladesh,
1001 in Nepal, and 939 in Pakistan. The median age of the participants was 10 years (interquartile range [IQR], 5–25 years),
and 1246 (42.4%) of the participants were female. The median
temperature at hospital presentation was 37.2 C (IQR, 36.7–
38.2), and patients reported a median of 4 days (IQR, 3–6 days)
of fever (Table 1). All participants had a blood culture, and 373
(12.7%) tested positive for S. Typhi or S. Paratyphi. Culture positivity was higher in Bangladesh (20.1%) and Pakistan (14.5%)
and lower in Nepal (3.6%).
Overall, we detected antibiotics in the urine samples of 1145
(39%) participants: 377 (37.7%) in Bangladesh, 264 (26.4%) in
Nepal, and 504 (53.8%) in Pakistan. In contrast, 1259 (43.7%)
participants reported taking antibiotics prior to seeking care:
412 (42.4%) in Bangladesh, 417 (42.4%) in Nepal, and 430
(46.2%) in Pakistan (Table 1). In Bangladesh and Nepal, reported antibiotic use was higher than the detected antibiotics
across all age groups (Figure 1).

5 (highest)

Highest education, female head of household
None

23 (5.2)

158 (39.7)

144 (27.6)

325 (23.8)

Primary

204 (45.8)

80 (20.1)

96 (18.4)

380 (27.9)

Secondary

130 (29.2)

93 (23.4)

133 (25.5)

356 (26.1)

88 (19.8)

67 (16.8)

148 (28.4)

303 (22.2)

Postsecondary

Data are presented as no. (%) unless otherwise indicated.
Abbreviation: IQR, interquartile range.

When asked about care-seeking for the current illness prior
to presentation at the study hospital, the most common location reported was a pharmacy, followed by a hospital or clinic.
However, there were substantial differences between countries.
For example, only 2.4% of the participants sought care at a
pharmacy in Pakistan compared with 56.7% in Bangladesh and
59.6% in Nepal (Table 1). In Nepal, the percentage of children
taken to the hospital decreased with age, while the percentage
of patients visiting a pharmacy increased with age (Figure 2).
However, this finding was not observed in other sites.
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component analysis to construct a wealth index variable from
the household asset data for these analyses. We used binomial
mixed-effect logit models for all the remaining analyses with
random effects for hospital site and country to account for clustering. We report the results as prevalence ratios, calculated
from the probability-logit transformations from the mixed
models [20]. We calculated the sensitivity and specificity of reported antibiotic use with antibiotics detected in the urine as
the reference standard.
We evaluated the relationship between antibiotics detected in
the urine and blood culture positivity for S. Typhi/S. Paratyphi. We
ran an unadjusted model (model 1) alongside a model adjusted for
markers of disease severity (days unable to complete normal activity
and hours spent in bed on the worst day of illness), days of fever,
and age, which we hypothesized might confound the association
between the antibiotic use and culture positivity.
We anticipated that 30% of the study patients would have
antibiotics detected in their urine. To estimate prevalence across
the 3 age groups with a width of the 95% CI of ±5% required 969
participants per site.
We used R version 3.6.0 software for all our analyses.

Figure 2. Age and facility care-seeking for current illness by country, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal, and Pakistan, 2016–2019.
Percentage of patients seeking care at a clinic, hospital, pharmacy, physician, or traditional healer prior to presenting to the study site among 2939 outpatients with ≥3 consecutive days of fever in Bangladesh, Nepal, and Pakistan.

Antibiotic detection in urine was positively associated with
having ≥7 days of fever (prevalence ratio [PR], 1.32 [95% CI,
1.19–1.45]), temperature of 38.3 C at presentation (PR, 1.19
[95% CI, 1.06–1.32]), having ≥3 days of being unable to conduct
normal activities (PR, 1.14 [95% CI, 1.03–1.26]), and having diarrhea (PR, 1.19 [95% CI, 1.03–1.35]) (Table 2). Seeking care
S288 • cid 2020:71 (Suppl 3) • Vaidya et al

at a hospital, clinic, or pharmacy or with a physician for the
current illness prior to presenting to the study hospital was also
associated with a higher probability of detecting antibiotics in
the urine samples (Table 2). There was no apparent association
between wealth or education and antibiotics being detected in
the urine (Table 2). These associations were consistent at the
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Figure 1. Differences between antibiotic detection and report across study country and age strata, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal,
and Pakistan, 2016–2019. Differences in the percentage of patients reporting antibiotic use and patients with antibiotics detected in the urine by country and age category
among 2939 outpatients with ≥3 consecutive days of fever in Bangladesh, Nepal, and Pakistan. Vertical line in the middle of each bar depicts the 95% confidence interval
around the percentage.

Table 2. Antibiotic Detection in Urine by Demographic and Behavioral
Factors, Surveillance for Enteric Fever in Asia Project—Bangladesh,
Nepal, and Pakistan, 2016–2018

Characteristic

Antibiotics
Total
Detected (n = 1145), (N = 2939),
No. (%)
No.

Table 2. Continued

Characteristic
PR
(95% CI)

P
Value

5 (highest)

Antibiotics
Total
Detected (n = 1145), (N = 2939),
No. (%)
No.
86 (31.5)

273

PR
(95% CI)
1.03
(.80–1.26)

P
Value
.803

Female head of household, highest education attained

Age, y
55 (43.0)

128

Ref

2–4

223 (38.8)

575

0.91
(.70–1.14)

.429

5–15

394 (36.0)

1093

0.83
(.64–1.05)

.122

16–25

134 (34.7)

386

0.96
(.72–1.22)

.753

>25

339 (45.0)

754

1.11 (.88–1.35) .363

Male

652 (38.6)

1691

Ref

Female

493 (39.6)

1245

1.02
(.92–1.12)

No

859 (36.5)

2356

Yes

279 (50.0)

558

Sex

None

123 (38.0)

324

Ref

Primary

161 (42.5)

379

1.14
(.92–1.36)

.224

Secondary

134 (37.6)

356

0.95
(.75–1.17)

.648

Postsecondary

128 (42.2)

303

1.02
(.80–1.26)

.848

PRs are estimates using mixed-effect models with random effects for country and site
hospital and are adjusted for age.
Abbreviations: CI, confidence interval; PR, prevalence ratio.

.694

Fever duration ≥7 d
Ref
1.32 (1.19–
1.45)

<.001

Temperature at presentation 38.3 C
No

817 (39.6)

2064

Yes

236 (45.0)

524

Ref
1.19 (1.06–
1.32)

.004

≥3 d unable to conduct activity
No

399 (35.7)

1118

Ref

Yes

691 (42.3)

1635

1.14 (1.03–
1.26)

No

983 (37.8)

2600

Yes

162 (48.5)

334

.012

Reported diarrhea
Ref
1.19 (1.03–
1.35)

.018

Prior to enrollment, patient sought care at a hospital
No

786 (34.1)

2302

Yes

340 (56.1)

606

Ref
1.54 (1.40–
1.69)

<.001

Prior to enrollment, patient sought care at a pharmacya
No

862 (39.9)

2160

Yes

246 (33.9)

725

Ref
1.20 (1.07–
1.33)

.003

Prior to enrollment, patient sought care at a clinic
No

922 (36.8)

2508

Yes

201 (52.2)

385

Ref
1.31 (1.15–
1.47)

<.001

Prior to enrollment, patient sought care with a physician
No

950 (36.4)

2608

Yes

171 (58.6)

292

a
Because of heterogeneity in care seeking and antibiotic use by country, antibiotic use
among individuals who sought care at a pharmacy appears lower than those who did not
seek care at a pharmacy; however, when accounting for differences by country in the
mixed-effect model, the PR for this association is higher.

Ref
1.43 (1.24–
1.62)

<.001

country level as well, barring the association between diarrhea
and antibiotic detection in Bangladesh and seeking care at a
pharmacy and antibiotic detection in Nepal (Table 3).
Individuals who had antibiotics detected in their urine
were more likely to be blood culture positive for S. Typhi or S.
Paratyphi A compared with individuals who had no antibiotics
in their urine (PR, 1.33 [95% CI, 1.10–1.60]). When adjusting
for the duration of fever, days in bed, diarrhea, age, and wealth,
the prevalence ratio decreased to 1.22 (95% CI, .99–1.50) and
was no longer statistically significant (P = .065) (Table 4).
When restricting to patients with a clinical diagnosis of enteric
fever, individuals with antibiotics in their urine were still more
likely to be blood culture positive for S. Typhi or S. Paratyphi
compared with those who had no antibiotics detected in their
urine in the unadjusted analysis (PR, 1.29 [95% CI, 1.05–1.55];
P = .014).
The sensitivity and specificity of reported antibiotic use compared to the detection of antibiotics in the urine were 70.2% (95%
CI, 57.9%–80.2%) and 72.6% (95% CI, 66.1%–79.1%), respectively. Correlation between measured and reported antibiotic
use was modest in all 3 countries but was higher in Bangladesh
(κ = 0.74) and Nepal (κ = 0.73) than in Pakistan (κ = 0.62). The
sensitivity of reported antibiotic use was slightly higher for parents
and guardians compared to self-report (Table 5).

Prior to enrollment, patient sought care with a traditional healer
No

1119 (38.7)

2893

Yes

7 (46.7)

15

Ref
1.10
(.54–1.75)

.761

Wealth index quintile
1 (lowest)

125 (45.8)

273

Ref

2

126 (46.2)

273

1.10
(.90–1.30)

.333

3

101 (37.1)

272

0.92
(.71–1.15)

.511

4

104 (38.1)

273

1.05
(.82–1.27)

.697

DISCUSSION

Antibiotic use prior to presentation to hospitals may have important implications for diagnostic evaluation by clinicians
and for pathogen surveillance systems. However, the reliability of self-report of recent antibiotic use is unclear, and
whether individuals who report prior antibiotic use should
be included in blood culture–based surveillance systems has
been debated. To address these knowledge gaps, we evaluated
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<2

Table 3. Country-level Associations With Antibiotic Detection in Urine, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal, and Pakistan,
2016–2019
Bangladesh
PR (95% CI)

Characteristic

Nepal
P Value

PR (95% CI)

Pakistan
P Value

PR (95% CI)

P Value

Age, y
Ref
0.88 (.64–1.16)

.398

1.12 (.34–2.84)

Ref
.842

0.95 (.59–1.31)

Ref
.795

5–15

0.75 (.53–1.01)

.061

1.41 (.47–3.20)

.518

0.89 (.57–1.22)

.527

16–25

…

1.47 (.49–3.28)

.463

1.02 (.67–1.36)

.900

>25

…

1.83 (.65–3.72)

.230

1.13 (.80–1.43)

.434

.078

0.92 (.73–1.13)

.421

0.98 (.86–1.09)

.711

Female sex

1.16 (.98–1.34)

Fever duration ≥7 da

1.52 (1.29–1.75)

<.001

1.17 (.88–1.50)

.262

1.22 (1.06–1.36)

.006

Temperature at presentation >38.3 Ca

1.34 (1.11–1.57)

.004

1.39 (1.04–1.78)

.027

1.02 (.87–1.16)

.810

≥3 d unable to conduct activitya

1.13 (.95–1.32)

.172

1.24 (.98–1.54)

.067

1.15 (1.01–1.29)

.042

Diarrheaa

0.92 (.63–1.26)

.631

1.19 (.86–1.58)

.275

1.25 (1.09–1.40)

.003

Hospital

1.65 (1.34–1.94)

<.001

2.03 (1.65–2.42)

<.001

1.25 (1.11–1.37)

<.001

Pharmacy

1.64 (1.39–1.88)

<.001

0.89 (.70–1.11)

.292

1.05 (.61–1.44)

.843

Clinic

2.11 (.65–2.63)

.146

1.45 (1.11–1.83)

.007

1.19 (1.05–1.32)

.008

Physician

2.11 (1.77–2.39)

<.001

1.29 (.29–2.90)

.698

1.06 (.91–1.20)

.454

Traditional healer

1.36 (.63–2.08)

.377

0.00 (.00–3.81)

.911

0.57 (.06–1.56)

.441

Prior care-seeking for current illnessa

Wealth index quintile
1 (lowest)

Ref

2

0.93 (.59–1.34)

.744

Ref
1.19 (.52–2.13)

.647

Ref
1.15 (.92–1.36)

.199

3

0.75 (.44–1.15)

.210

0.81 (.33–1.66)

.616

1.05 (.82–1.27)

.683

4

1.04 (.68–1.43)

.849

0.71 (.28–1.49)

.400

1.23 (.97–1.46)

.083

5 (highest)

0.99 (.67–1.34)

.940

0.88 (.37–1.70)

.731

–

–

Female head of household, highest education attained
None

Ref

Primary

1.07 (.61–1.55)

.796

Ref
0.68 (.39–1.12)

.139

Ref
1.23 (.96–1.47)

.092

Secondary

0.76 (.38–1.27)

.351

0.73 (.44–1.15)

.192

1.17 (.92–1.40)

.177

Postsecondary

0.87 (.44–1.41)

.638

0.80 (.46–1.30)

.395

1.19 (.95–1.41)

.117

Abbreviations: CI, confidence interval; NaN, xxx; PR, prevalence ratio.
a

Adjusted for age.

Table 4. Antibiotic Detection in the Urine and Blood Culture Positivity, Surveillance for Enteric Fever in Asia Project—Bangladesh, Nepal, and Pakistan,
2016–2019
Model 2a

Model 1 (Unadjusted)
Detection
Overall

PR (95% CI)

P Value

PR (95% CI)

Model 3b
P Value

PR (95% CI)

P Value

1.29 (1.05–1.55)

.014

1.33 (1.1–1.6)

.004

1.22 (.99–1.5)

.065

Bangladesh

1.34 (1.05–1.67)

.019

1.25 (.96–1.6)

.102

1.28 (1.01–1.6)

.041

Nepal

1.77 (.92–3.3)

.088

1.38 (.52–3.54)

.518

0.69 (.19–2.27)

.557

Pakistan

1.19 (.87–1.59)

.277

1.26 (.9–1.71)

.171

1.38 (.97–1.89)

.074

Country

Abbreviations: CI, confidence interval; PR, prevalence ratio.
a

Model 2: Adjusted for fever duration, days unable to complete normal activity, temperature at presentation, age, wealth.
Model 3: Restricted to participants with a clinically suspected enteric fever diagnosis.

b

antibiotic use, self-report, and blood culture positivity among
a subset of outpatients presenting to hospitals in Bangladesh,
Nepal, and Pakistan. Antibiotic use across all 3 countries was
high, with 1 of every 3 participants having antibiotic activity
confirmed in their urine assay upon presenting at the tertiary
care study site. Patients presenting with more severe disease
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(higher temperature at presentation, more days of fever, diarrhea, and longer time unable to complete normal activities)
were more likely to have taken antibiotics than those with
less severe disease. Many patients had sought care at other
facilities prior to presenting at the study-site facility; of these,
those who sought care at other hospitals or with physicians
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<2
2–4

Table 5. Sensitivity and Specificity of Antibiotic Use Reporting by Country and Caregiver Type, Surveillance for Enteric Fever in Asia Project—Bangladesh,
Nepal, and Pakistan, 2016–2019
Variable

TPa

FNb

TNc

FPd

Sensitivity, % (95% CI)

Specificity, % (95% CI)

Overall

781

342

1280

478

70.2 (57.9–80.2)

72.6 (66.1–79.1)

Country
288

74

485

124

75.2 (59.2–86.4)

80.5 (74.2–86.7)

Nepal

204

56

509

213

78.9 (64.5–88.5)

69.2 (61.3–77.0)

Pakistan

289

212

286

141

56.6 (40.0–71.8)

67.1 (58.5–75.6)

Self

279

152

435

161

67.4 (51.9–79.8)

69.5 (59.5–79.5)

Parent or guardian

454

166

770

279

72.3 (58.6–82.8)

74.8 (67.0–82.7)

47

24

71

38

70.3 (52.0–83.7)

68.6 (56.7–80.5)

<2

35

20

42

31

62.3 (42.0–79.0)

51.8 (36.3–67.2)

2–4

161

56

248

100

74.9 (60.8–85.2)

67.7 (57.5–77.8)

5–15

284

101

507

174

75.8 (62.9–85.2)

72.4 (63.8–80.9)

Respondent typee

Other relative
Age, y

16–25
>25

85

46

187

63

65.6 (49.0–79.0)

77.8 (69.2–86.5)

216

119

296

110

62.7 (47.5–75.8)

77.7 (69.7–85.7)

Abbreviations: CI, confidence interval; FN, false negative; FP, false positive; TN, true negative; TP, true positive.
a

True positive: Number of patients who reported antibiotic use and had antibiotics detected in their urine.

b

False negative: Number of patients who did not report antibiotic use who did have antibiotics detected in their urine.

c

True negative: Number of patients not reporting antibiotic use who did not have antibiotics detected in their urine.

d

False positive: Number of patients who reported antibiotic use who did not have antibiotics detected in their urine.

e

Adjusted for age.

were more likely to have taken antibiotics. In contrast to what
is often presumed, patients who had taken antibiotics prior
to presentation were more likely to be culture positive than
those who did not have evidence of antibiotics in their urine.
Finally, the accuracy of self-reported or caregiver-reported
antibiotic use compared to antibiotics detected in the urine
was modest in all 3 countries.
The impact of antimicrobial use on the sensitivity of blood
culture of S. Typhi and S. Paratyphi is not well characterized
[21]. A recent meta-analysis found that reported prior antibiotic use was associated with a 34% decreased sensitivity of
blood culture, although the size of the studies was small and
there was substantial heterogeneity between them. Additionally,
all studies were performed between the 1970s and 1990s, when
different antibiotics were used for treatment of suspected enteric fever than those commonly used today. To investigate the
impact of currently used antibiotics (eg, azithromycin, cefixime,
and ceftriaxone) on culture sensitivity, a reference standard not
strongly affected by antibiotics is needed. Historically, studies
have used bone marrow cultures, which are less rapidly affected
by antibiotics due to higher bacterial concentrations; however,
this procedure is invasive, painful, and not widely performed
today. Newer serologic diagnostics have demonstrated promise
for improving the diagnosis of typhoid and may be useful as
non-culture-based references for future studies [22, 23].
While we found higher culture positivity among individuals
with prior antibiotic use, we believe that this was due to confounding whereby individuals who continued to have fever despite continued antibiotic use are more likely to have typhoid

than other illnesses. The duration of fever in typhoid is characteristically longer than the other common causes of fever. Even
after antibiotic use, the average fever clearance time in clinical
trials for enteric fever treatment is around 5 days [24]. Persistent
fever despite antibiotic use may therefore be a marker of enteric
fever. This may be particularly true if individuals received antibiotics to which their S. Typhi or S. Paratyphi A isolate was not
susceptible. Because antimicrobial resistance was widespread
and fairly homogeneous within study sites, and the assay we
used could not distinguish between specific antibiotics, we were
unable to assess whether antimicrobial resistance mediated the
effects of prior antibiotic use on culture positivity.
While self- or caregiver-reported antibiotic use is widely
thought to be inaccurate, few studies have documented the
validity of reported antibiotic use against a urine antibacterial
assay in the South Asia region [10–13]. Our results were comparable to a study of young children with respiratory tract infections in the Philippines, where the sensitivity and specificity
of caregiver-reported antibiotic use were 59% and 71%, respectively [25]. The low sensitivity documented in our study indicates that both clinicians and researchers should use caution
when interpreting self- and caregiver-reported antibiotic use.
The results of this study should be interpreted within the
context of the limitations of the design and study procedures.
Biologic assays for antibiotic metabolites in urine may have limited sensitivity, which could lead to underestimation of prior
antibiotic use and bias associations between demographic and
clinical features, likely toward the null [26]. Their accuracy
likely varies by antibiotic class, the number of doses taken, and
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recentness of the last dose. We did not have data about timing
of doses or concentrations of antibiotics or their metabolites in
urine over time. The assay used in our study did not enable us
to distinguish between different antibiotic classes. It is possible
that nonantibiotic metabolites in the urine or other chemical
properties (eg, pH, urea, and ammonia concentrations) could
have inhibited Kocuria growth, leading to false-positive results
[27–29]. Although we did not observe bacterial inhibition in
urine collected from healthy controls individuals during a pilot
phase, it is possible that these chemical properties are altered in
individuals with acute illness.
Despite these limitations, this is the largest study to date
evaluating prior antibiotic use among enteric fever suspects
and the associations with culture positivity and self-reported
use. We unexpectedly found that individuals with reported
antibiotic use were more likely to be culture positive for enteric fever; however, this relationship was confounded by disease severity. While antibiotics may reduce the sensitivity of
blood culture, our findings indicate that there is still considerable value in performing blood culture among individuals
reporting antibiotic use. Given the continuing emergence
and spread of antimicrobial resistance among typhoidal
Salmonella [15, 30], a better understanding of the relationship
between antibiotic usage patterns and typhoid detection and
resistance may improve our ability to monitor and respond to
this epidemic.

